|
Phase 0
|
NCT06171282 |
Jul 2023 → Jul 2025 |
bone neoplasm, osteosarcoma, soft tissue sarcoma |
Shanghai Yunying Medical Technology |
Unknown
|
No outcome recorded
|
|
Phase 0
|
NCT05961111 |
Jun 2023 → Jun 2025 |
brain cancer, breast cancer, carcinoma, digestive system cancer +6 |
Shanghai Yunying Medical Technology |
Unknown
|
No outcome recorded
|
|
Phase 0
|
NCT05851456 |
Apr 2023 → Apr 2025 |
bone neoplasm, osteosarcoma, soft tissue sarcoma |
Shanghai Yunying Medical Technology |
Unknown
|
No outcome recorded
|
|
Phase 0
|
NCT05886075 |
Mar 2023 → Mar 2025 |
breast cancer, bronchus cancer, colorectal cancer, gastric cancer +7 |
Shanghai Yunying Medical Technology |
Unknown
|
No outcome recorded
|
|
Phase 0
|
NCT05830240 |
Mar 2023 → Mar 2025 |
esophageal cancer, larynx cancer, nasal cavity cancer, pharynx cancer |
Shanghai Yunying Medical Technology |
Unknown
|
No outcome recorded
|
|
Phase 0
|
NCT05860374 |
Mar 2023 → Mar 2025 |
breast cancer, carcinoma, colorectal cancer, female reproductive organ cancer +5 |
Shanghai Yunying Medical Technology |
Unknown
|
No outcome recorded
|
|
Phase 0
|
NCT05812677 |
Feb 2023 → Feb 2025 |
cervical cancer, endometrial cancer |
Shanghai Yunying Medical Technology |
Unknown
|
No outcome recorded
|
|
Phase 0
|
NCT05801783 |
Dec 2022 → Dec 2024 |
fallopian tube cancer, ovarian cancer, peritoneal carcinomatosis |
Shanghai Yunying Medical Technology |
Unknown
|
No outcome recorded
|